Qiagen Net Debt vs Good Will Analysis
QGEN Stock | USD 42.78 0.45 1.06% |
Qiagen NV financial indicator trend analysis is much more than just breaking down Qiagen NV prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Qiagen NV is a good investment. Please check the relationship between Qiagen NV Net Debt and its Good Will accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.
Net Debt vs Good Will
Net Debt vs Good Will Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Qiagen NV Net Debt account and Good Will. At this time, the significance of the direction appears to have strong relationship.
The correlation between Qiagen NV's Net Debt and Good Will is 0.76. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Good Will in the same time period over historical financial statements of Qiagen NV, assuming nothing else is changed. The correlation between historical values of Qiagen NV's Net Debt and Good Will is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Qiagen NV are associated (or correlated) with its Good Will. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Good Will has no effect on the direction of Net Debt i.e., Qiagen NV's Net Debt and Good Will go up and down completely randomly.
Correlation Coefficient | 0.76 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Most indicators from Qiagen NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Qiagen NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.At this time, Qiagen NV's Selling General Administrative is very stable compared to the past year. As of the 22nd of November 2024, Enterprise Value Over EBITDA is likely to grow to 29.48, while Tax Provision is likely to drop about 46.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.5B | 1.4B | 1.2B | 664.0M | Total Revenue | 2.3B | 2.1B | 2.0B | 1.0B |
Qiagen NV fundamental ratios Correlations
Click cells to compare fundamentals
Qiagen NV Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Qiagen NV fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 5.2B | 6.0B | 6.1B | 6.3B | 6.1B | 3.2B | |
Short Long Term Debt Total | 1.7B | 2.0B | 1.9B | 1.9B | 1.6B | 903.4M | |
Other Current Liab | 532.8M | 273.3M | 455.5M | 381.0M | 306.0M | 321.3M | |
Total Current Liabilities | 951.3M | 613.8M | 1.5B | 974.5M | 1.1B | 1.1B | |
Total Stockholder Equity | 2.5B | 2.5B | 3.1B | 3.5B | 3.8B | 4.0B | |
Property Plant And Equipment Net | 455.2M | 528.6M | 638.2M | 662.2M | 870.3M | 913.8M | |
Net Debt | 1.1B | 1.4B | 1.1B | 1.1B | 943.0M | 494.1M | |
Retained Earnings | 868.8M | 758.5M | 1.5B | 2.2B | 2.5B | 2.6B | |
Accounts Payable | 84.8M | 118.2M | 101.2M | 98.7M | 84.2M | 48.7M | |
Cash | 623.6M | 597.0M | 880.5M | 730.7M | 668.1M | 409.2M | |
Non Current Assets Total | 3.7B | 4.3B | 4.0B | 3.9B | 4.0B | 2.2B | |
Non Currrent Assets Other | 188.4M | 423.8M | 157.6M | 254.4M | 65.3M | 109.0M | |
Cash And Short Term Investments | 753.2M | 714.3M | 1.1B | 1.4B | 1.1B | 1.1B | |
Net Receivables | 427.2M | 439.9M | 469.7M | 333.5M | 515.6M | 541.4M | |
Common Stock Shares Outstanding | 220.0M | 227.2M | 225.1M | 223.2M | 223.7M | 202.8M | |
Liabilities And Stockholders Equity | 5.2B | 6.0B | 6.1B | 6.3B | 6.1B | 3.2B | |
Non Current Liabilities Total | 1.7B | 2.9B | 1.5B | 1.8B | 1.2B | 1.0B | |
Inventory | 170.7M | 291.2M | 327.5M | 358.0M | 398.4M | 418.3M | |
Other Current Assets | 105.5M | 204.3M | 247.1M | 284.2M | 175.8M | 184.5M | |
Other Stockholder Equity | 2.0B | 1.7B | 1.6B | 1.7B | 1.8B | 1.1B | |
Total Liab | 2.7B | 3.5B | 3.1B | 2.8B | 2.3B | 1.4B | |
Total Current Assets | 1.6B | 1.6B | 2.1B | 2.4B | 2.1B | 2.3B | |
Accumulated Other Comprehensive Income | (309.6M) | (239.6M) | (326.7M) | (404.1M) | (433.8M) | (412.1M) | |
Short Term Debt | 285.2M | 66.0M | 869.7M | 411.8M | 610.2M | 640.7M | |
Short Term Investments | 129.6M | 117.2M | 184.8M | 687.6M | 389.7M | 409.2M | |
Intangible Assets | 632.4M | 883.6M | 627.4M | 544.8M | 526.8M | 465.5M | |
Other Liab | 280.9M | 516.4M | 438.8M | 411.9M | 473.7M | 497.4M | |
Current Deferred Revenue | 48.5M | 57.1M | 63.4M | 69M | 66.4M | 63.1M | |
Other Assets | 294.9M | 468.6M | 421.0M | 269.6M | 1.0 | 0.95 | |
Long Term Debt | 1.4B | 1.9B | 1.1B | 1.5B | 921.8M | 936.7M | |
Property Plant Equipment | 512.5M | 661.9M | 638.2M | 586.6M | 674.5M | 406.3M | |
Good Will | 2.1B | 2.4B | 2.4B | 2.4B | 2.5B | 2.3B | |
Long Term Investments | 75.5M | 87.1M | 15.4M | 23.5M | 21.2M | 39.6M | |
Short Long Term Debt | 285.2M | 42.5M | 847.6M | 389.6M | 588.0M | 418.6M | |
Net Tangible Assets | (236.3M) | (292.4M) | 118.4M | 293.6M | 337.6M | 354.5M |
Pair Trading with Qiagen NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.Moving together with Qiagen Stock
0.64 | A | Agilent Technologies Earnings Call This Week | PairCorr |
0.77 | ME | 23Andme Holding | PairCorr |
0.72 | VALN | Valneva SE ADR | PairCorr |
Moving against Qiagen Stock
0.76 | EWTX | Edgewise Therapeutics | PairCorr |
0.75 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.57 | EXEL | Exelixis | PairCorr |
0.54 | FLGC | Flora Growth Corp | PairCorr |
0.46 | KTTAW | Pasithea Therapeutics | PairCorr |
The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.
The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.255 | Earnings Share 0.45 | Revenue Per Share 8.841 | Quarterly Revenue Growth 0.055 | Return On Assets 0.0484 |
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.